This seems almost inevitable, yes? Jon Paul Morosi:
The Atlanta Braves, looking to add an outfield bat, have interest in signing free-agent outfielder Cody Ross, according to a major-league source.
With Torii Hunter likely choosing between the Rangers and Tigers, the Braves are pursuing another of the top right-handed bats on the market. Ross posted an .807 OPS with 22 home runs in 130 games with the Boston Red Sox this year.
They could do worse. They have holes in left field and third base, and Martin Prado will play in one of those positions. Assuming that the Braves aren’t in Torii Hunter or Josh Hamilton’s tax bracket, Cody Ross is a better option than anyone else, either at third or left. Him or Ryan Ludwick, I guess.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.